January 6-7, 2022 webconference

The Longwood Healthcare Leaders meeting, centered on Stanford/San Francisco via webconference on Thursday, January 6 - Friday, January 7, 2022 prior to the JP Morgan Healthcare Conference, brings together leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors for an off-the-record forum focused on accelerating the translation of discoveries into medicines to help patients.

Speakers include Stanford University President Marc Tessier-Lavigne, Stanford School of Medicine Dean Lloyd Minor, Daiichi Sankyo Executive Chair, head of R&D, and President Glenn Gormley, AbbVie Chief Strategy Officer Henry Gosebruch, SeaGen CEO Clay Siegall, Nestle Health Science CEO Greg Behar, Vir Bio CMO Phil Pang, Alladapt CEO Ashley Dombkowski, Xontogeny CEO Chris Garabedian, Takeda Neuroscience head Beth Shafer, Genocea CEO Chip Clark, among others. Substantial donations enabled by these meetings benefit Life Science Cares, The Boston Foundation, BSO, Harvard Medical School, MIT, and other charities.

Supporters

We are grateful to the following organizations for their support of this meeting. To learn more about getting involved contact susan@longwoodfund.com

BenchSci's vision is to help scientists bring novel medicine to patients 50% faster by 2025. We do this by empowering scientists to run more successful experiments with the world's most advanced, intuitive biomedical artificial intelligence software platform, thereby avoiding delays that slow the progress of medicine to clinical trials. BenchSci is an indispensable tool for more than 41,000 scientists that accelerates research at 15 top 20 pharmaceutical companies and over 4,300 leading academic centers.

LONGWOOD HEALTHCARE LEADERS WINTER MEETING | DRAFT AGENDA | JANUARY 6-7, 2022

- all times Pacific Standard –

7:00 – 7:30 | LONGWOOD FUND INTRODUCTION

7:30 – 8:00 | NEWCO TO ESTABLISHED: BUILDING A BIOTECH

8:00 – 8:30 | R&D COLLABORATION

8:30 – 8:50 | FIRESIDE CHAT
Marc Tessier-Lavigne, President, Stanford; Lloyd Minor, Dean, Stanford Medicine

8:50 – 9:20 | BULDING GLOBAL BIOPHARMAS

9:20 – 9:50 | IPO MARKET FORCAST

9:50 – 10:20 | SOURCING AND IDENTIFYING NOVEL TECHNOLOGY

10:20 – 10:40 | FIRESIDE CHAT

10:40 – 11:10 | INNOVATION IN CELL THERAPY

11:10 – 11:40 | CULTIVATING AN ECOSYSTEM OF PARTNERS

11:40 – 12:00 | FIRESIDE CHAT

12:00 – 12:30 | HOW M&A SPURS INNOVATION

12:30 – 1:00 | SCIENTIFIC INNOVATION: LAUNCHING COMPANIES FROM ACADEMIA

1:00 – 1:30 | ADVANCING PLATFORM TECHNOLOGIES

1:30 – 1:50 | FIRESIDE CHAT

1:50 – 2:20 | EXPEDITING RESEARCH FOR TREATMENTS AND CURES

2:20 – 2:50 | ALTERNATIVE SOURCES OF FINANCING

2:50 – 3:20 | ACCELERATING DRUG DEVELOPMENT

3:20 – 3:40 | FIRESIDE CHAT

3:40 – 4:10 | MAKING A BIG IMPACT WITH LIMITED RESOURCES

4:10 – 4:40 | DRUG APPROVALS: INSIGHTS, OUTLOOK, AND COMMITMENT TO PATIENTS

4:40 – 5:10 | BUSINESS DEVELOPMENT: SELECTING THE RIGHT PARTNER

5:10 – 5:40 | MAKING SMART INVESTMENTS

5:40 – 6:00 | LONGWOOD FUND SUMMARY

FRIDAY, JANUARY 7, 2022

7:00 – 7:30 | LONGWOOD FUND INTRODUCTION

7:30 – 8:00 | HARNESSING BIOMEDICAL INNOVATION

8:00 – 8:20 | MODERATED KEYNOTE

8:20 – 8:50 | HEALTH SYSTEMS IN A NEW ERA

8:50 – 9:20 | BIG BIOPHARMA R&D

9:20 – 9:50 | SPOTLIGHT: STANFORD INNOVATION

9:50 – 10:20 | THE NEXT WAVE OF TARGETED THERAPIES

10:20 – 10:40 | FIRESIDE CHAT

10:40 – 11:10 | DESIGNING THE DEAL

11:10 – 11:40 | BIOPHARMA REGULATORY & INDUSTRY TRENDS

11:40 – 12:10 | GETTING TO DRUG APPROVAL

12:10 – 12:30 | FIRESIDE CHAT

12:30 – 1:00 | FINANCING INNOVATION

1:00 – 1:30 | CLINICAL TRIAL DIVERSITY

1:30 – 2:00 | NOVEL THERAPEUTIC MODALITIES

2:00 – 2:20 | FIRESIDE CHAT

2:20 – 2:50 | R&D TRANSFORMATION

2:50 – 3:20 | INNOVATION HUBS

3:20 – 3:40 | FIRESIDE CHAT

3:40 – 4:10 | NOVEL APPROACHES TO DUG DISCOVERY

4:10 – 4:40 | THE NEXT WAVE OF FINANCINGS: IPOS, REVERSE MERGERS, SPACS

4:40 – 5:00 | FIRESIDE CHAT

5:00 – 5:30 | EXTERNAL INNOVATION

5:30 – 6:00 | INNOVATIVE PARTNERSHIPS

6:00 – 6:30 | LONGWOOD FUND SUMMARY